登录 | 注册    关注公众号  
微信公众号
搜索
 >  Protein>IL-18 R beta >ILB-H52H8

Human IL-18 R beta / IL-1 R7 Protein, His Tag

分子别名(Synonym)

IL-18 R beta,IL-1 R7,CD218b,CDw218b,IL-1 R7,IL-18 R beta,IL-18 receptor accessory protein,IL-18 receptor beta,IL18R beta,IL-18RAcP

表达区间及表达系统(Source)

Human IL-18 R beta, His Tag (ILB-H52H8) is expressed from human 293 cells (HEK293). It contains AA Phe 20 - Arg 356 (Accession # O95256-1).

Predicted N-terminus: Phe 20

Request for sequence

蛋白结构(Molecular Characterization)

Online(Phe 20 - Arg 356) O95256-1

This protein carries a polyhistidine tag at the C-terminus.

The protein has a calculated MW of 40.3 kDa. The protein migrates as 55-60 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

内毒素(Endotoxin)

Less than 1.0 EU per μg by the LAL method.

纯度(Purity)

>95% as determined by SDS-PAGE.

制剂(Formulation)

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

Contact us for customized product form or formulation.

重构方法(Reconstitution)

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage)

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. -20°C to -70°C for 12 months in lyophilized state;
  2. -70°C for 3 months under sterile conditions after reconstitution.
 

电泳(SDS-PAGE)

Human IL-18 R beta, His Tag (Cat. No. ILB-H52H8) SDS-PAGE gel

Human IL-18 R beta, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.

背景(Background)

 

 

前沿进展

 
 
货号/价格
产品推荐
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
IL-18 R beta靶点信息
英文全称:Interleukin-18 receptor accessory protein
中文全称:IL18受体辅助蛋白
种类:Homo sapiens
上市药物数量:0详情
临床药物数量:0详情
最高研发阶段:
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定